Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) (gfy407) DOI: 10.1093/NDT/gfy407)

1. Sarafidis, P.
2. Ferro, C.J.
3. Morales, E.
4. Ortiz, A.
5. Malyszko, J.
6. Hojs, R.
7. Khazim, K.
8. Ekart, R.
9. Valdivielso, J.
10. Fouque, D.
11. London, G.M.
12. Massy, Z.
13. Ruggenenti, P.
14. Porrini, E.
15. Wiecek, A.
16. Zoccali, C.
17. Mallamaci, F.
18. Hornum, M.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/NDT/GFZ137 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus